Rafael Holdings Inc

RFL

Company Profile

  • Business description

    Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

  • Contact

    520 Broad Street
    NewarkNJ07102
    USA

    T: +1 212 658-1450

    E: [email protected]

    https://www.rafaelholdings.com

  • Sector

    Real Estate

    Stock type

    Cyclical

  • Industry

    Real Estate Services

    Fiscal Year End

    31 July 2026

    Employees

    31

Stocks News & Analysis

stocks

Undervalued ASX founder-led companies

Can this strategy pick the winners?
stocks

AI stocks post big gains in Q3. These are the winners and losers

Alphabet and Teradyne post big gains, while Salesforce and Adobe were down in the quarter.
stocks

12 picks for an income portfolio - Q3 2025 update

Fifteen months in and passive income growth has exceeded my target.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,253.6025.70-0.28%
CAC 407,971.78109.76-1.36%
DAX 4024,378.290.51-0.00%
Dow JONES (US)46,694.9763.31-0.14%
FTSE 1009,479.1412.11-0.13%
HKSE26,957.77183.15-0.67%
NASDAQ22,941.67161.160.71%
Nikkei 22548,027.8183.050.17%
NZX 50 Index13,531.2942.050.31%
S&P 5006,740.2824.490.36%
S&P/ASX 2008,956.8019.10-0.21%
SSE Composite Index3,882.7820.250.52%

Market Movers